155 related articles for article (PubMed ID: 22973723)
41. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
[TBL] [Abstract][Full Text] [Related]
42. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression.
Lu XX; Yu JL; Ying LS; Han J; Wang S; Yu QM; Wang XB; Fang XH; Ling ZQ
Cancer; 2012 Nov; 118(22):5507-17. PubMed ID: 22576578
[TBL] [Abstract][Full Text] [Related]
43. Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer.
Wanajo A; Sasaki A; Nagasaki H; Shimada S; Otsubo T; Owaki S; Shimizu Y; Eishi Y; Kojima K; Nakajima Y; Kawano T; Yuasa Y; Akiyama Y
Gastroenterology; 2008 Aug; 135(2):580-90. PubMed ID: 18588891
[TBL] [Abstract][Full Text] [Related]
44. [Methylation of some miRNA genes is involved in the regulation of their target genes RAR-beta2 and NKIRAS1 expression in lung cancer].
Khodyrev DS; Pronina IV; Rykov SV; Beresneva EV; Fridman MV; Kazubskaia TP; Loginov VI; Braga ÉA
Mol Biol (Mosk); 2012; 46(5):773-85. PubMed ID: 23156677
[TBL] [Abstract][Full Text] [Related]
45. Epigenetic Silencing of the Putative Tumor Suppressor Gene GLDC (Glycine Dehydrogenase) in Gastric Carcinoma.
Min HL; Kim J; Kim WH; Jang BG; Kim MA
Anticancer Res; 2016 Jan; 36(1):179-87. PubMed ID: 26722042
[TBL] [Abstract][Full Text] [Related]
46. Quantitative DNA methylation analysis for epigenotyping of colorectal cancer.
Kaneda A; Yagi K
Methods Mol Biol; 2015; 1238():289-99. PubMed ID: 25421666
[TBL] [Abstract][Full Text] [Related]
47. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.
Toiyama Y; Okugawa Y; Goel A
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):43-57. PubMed ID: 25128828
[TBL] [Abstract][Full Text] [Related]
48. Fluctuations of epigenetic regulations in human gastric Adenocarcinoma: How does it affect?
Samadani AA; Noroollahi SE; Mansour-Ghanaei F; Rashidy-Pour A; Joukar F; Bandegi AR
Biomed Pharmacother; 2019 Jan; 109():144-156. PubMed ID: 30396071
[TBL] [Abstract][Full Text] [Related]
49. Epigenetics in gastric carcinogenesis: TET genes as important players.
Necula LG; Mambet C; Albulescu R; Diaconu CC
J Immunoassay Immunochem; 2015; 36(5):445-55. PubMed ID: 25714048
[TBL] [Abstract][Full Text] [Related]
50. Epigenetics of gastric cancer.
Guo M; Yan W
Methods Mol Biol; 2015; 1238():783-99. PubMed ID: 25421692
[TBL] [Abstract][Full Text] [Related]
51. Epigenetic field for cancerization.
Ushijima T
J Biochem Mol Biol; 2007 Mar; 40(2):142-50. PubMed ID: 17394762
[TBL] [Abstract][Full Text] [Related]
52. Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers.
Wong CC; Li W; Chan B; Yu J
Semin Cancer Biol; 2019 Apr; 55():90-105. PubMed ID: 29665409
[TBL] [Abstract][Full Text] [Related]
53. Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer.
Grady WM; Parkin RK; Mitchell PS; Lee JH; Kim YH; Tsuchiya KD; Washington MK; Paraskeva C; Willson JK; Kaz AM; Kroh EM; Allen A; Fritz BR; Markowitz SD; Tewari M
Oncogene; 2008 Jun; 27(27):3880-8. PubMed ID: 18264139
[TBL] [Abstract][Full Text] [Related]
54. Epigenetics of colorectal cancer.
Yan W; Guo M
Methods Mol Biol; 2015; 1238():405-24. PubMed ID: 25421673
[TBL] [Abstract][Full Text] [Related]
55. Hypermethylation in gastric cancer.
Li Y; Liang J; Hou P
Clin Chim Acta; 2015 Aug; 448():124-32. PubMed ID: 26148722
[TBL] [Abstract][Full Text] [Related]
56. Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer.
Lim B; Kim JH; Kim M; Kim SY
World J Gastroenterol; 2016 Jan; 22(3):1190-201. PubMed ID: 26811657
[TBL] [Abstract][Full Text] [Related]
57. Tumor purity and differential methylation in cancer epigenomics.
Wang F; Zhang N; Wang J; Wu H; Zheng X
Brief Funct Genomics; 2016 Nov; 15(6):408-419. PubMed ID: 27199459
[TBL] [Abstract][Full Text] [Related]
58. Cooperative participation of epigenomic and genomic alterations in the clinicopathological diversity of gastric adenocarcinomas: significance of cell adhesion and epithelial-mesenchymal transition-related signaling pathways.
Yang M; Arai E; Takahashi Y; Totsuka H; Chiku S; Taniguchi H; Katai H; Sakamoto H; Yoshida T; Kanai Y
Carcinogenesis; 2020 Nov; 41(11):1473-1484. PubMed ID: 32710740
[TBL] [Abstract][Full Text] [Related]
59. Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer.
Marzese DM; Hoon DS
Expert Rev Mol Diagn; 2015 May; 15(5):647-64. PubMed ID: 25797072
[TBL] [Abstract][Full Text] [Related]
60. Outlook on Epigenetic Therapeutic Approaches for Treatment of Gastric Cancer.
Hudler P
Curr Cancer Drug Targets; 2018; 18(1):65-88. PubMed ID: 28176656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
